Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents
Abstract
This application describes the preparation and in vivo testing of surface coatings and matrix materials, which when applied to or caused to comprise the carriers for drugs and diagnostic agents, and administered in a fashion that allows efficient vascular access, causes the carriers to recognize determinants present or normal or focally diseased endothelium, and induces the following in vivo effects: (1) rapid, partial or total endothelial envelopment of the drug (diagnostic) carrier; (2) sequestration of the carrier and protecting entrapped agent from blood vascular clearance at an early time (2 minutes) when the endothelial pocket which envelops the carrier still invaginates into the vascular compartment; (3) acceleration of the carrier's transport across or through the vascular endothelium and/or subendothelial structures into the tissue compartment (interstitium); and (4) improvement of the efficiency with which the drug (or diagnostic) carrier migrates across the endothelium, or epi-endothelial or subendothelial barriers, such that a lower total drug dose is required to obtain the desired effect relative to that required for standard agents.
Term
Term ended
Projected expiry passed 30 March 2008, 18.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
52 members in 9 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 3343287 | United States of America | A | |
| 8801096 | United States of America | W | |
| 565119 | Canada | A |
Members52
| Document | Office | Kind | |
|---|---|---|---|
| WO8702893A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6621586A | Australia | A | |
| EP0247156A1 | European Patent Office (EPO) | A1 | |
| JPS63501798A | Japan | A | |
| WO8807365A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1627588A | Australia | A | |
| WO8807365A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0352295A1 | European Patent Office (EPO) | A1 | |
| US4925678A | United States of America | A | |
| CA1280364C | Canada | C | |
| AU607494B2 | Australia | B2 | |
| US5108759A | United States of America | A | |
| JPH04504404A | Japan | A | |
| US5155215A | United States of America | A | |
| EP0352295B1 | European Patent Office (EPO) | B1 | |
| EP0247156B1 | European Patent Office (EPO) | B1 | |
| AT90554T | Austria | T | |
| AT90879T | Austria | T | |
| ATE90554T1This record | Austria | T1 | |
| ATE90879T1 | Austria | T1 | |
| DE3881881D1 | Germany | D1 | |
| DE3688613D1 | Germany | D1 | |
| CA1324080C | Canada | C | |
| DE3881881T2 | Germany | T2 | |
| DE3688613T2 | Germany | T2 | |
| US5336762A | United States of America | A | |
| CA2177468A1 | Canada | A1 | |
| CA2177470A1 | Canada | A1 | |
| WO9514491A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9514492A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1262995A | Australia | A | |
| AU1332495A | Australia | A | |
| WO9514492A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9514491A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JPH07110815B2 | Japan | B2 | |
| EP0352295B2 | European Patent Office (EPO) | B2 | |
| EP0726781A1 | European Patent Office (EPO) | A1 | |
| EP0731713A1 | European Patent Office (EPO) | A1 | |
| DE3881881T3 | Germany | T3 | |
| JPH09509400A | Japan | A | |
| NZ277415A | New Zealand | A | |
| JPH09509650A | Japan | A | |
| US5672334A | United States of America | A | |
| US5707604A | United States of America | A | |
| NZ277928A | New Zealand | A | |
| AU688838B2 | Australia | B2 | |
| AU696166B2 | Australia | B2 | |
| JP2886171B2 | Japan | B2 | |
| EP0726781B1 | European Patent Office (EPO) | B1 | |
| AT204482T | Austria | T | |
| ATE204482T1 | Austria | T1 | |
| DE69428052D1 | Germany | D1 |
Numbers
- Application
- 88903702
Titles2
- English
- BIOADHESIVE DRUG CARRIER FOR ENDOTHELIAL AND EPITHELIAL UPTAKE AND LESIONAL LOCALIZATION OF THERAPEUTIC AND DIAGNOSTIC SUBSTANCES.
- German
- BIOADHAESIVER ARZNEITRAEGER ZUR ENDOTHELIALEN UND EPITHELIALEN AUFNAHME UND LAESIONALEN LOKALISIERUNG THERAPEUTISCHER UND DIAGNOSTISCHER STOFFE.
Classification
- CPC, 12
- A61K9/5146
- A61K9/1652
- A61K9/167
- A61K9/5036
- A61K9/5115
- A61K9/5161
- A61K9/5169
- Y10S436/829
- A61K47/61
- A61K47/69
- Y10T428/2989
- Y10T428/2984
- IPC, 10
- A61K9 127
- A61K9 16
- A61K9 50
- A61K9 51
- A61K31 70
- A61K47 36
- A61K47 40
- A61K47 42
- A61K47 48
- A61K49 00